| HGS |
HGS, HRS: Hepatocyte growth factor-regulated tyrosine kinase substrate |
FCGR2A |
FCGR2A, CD32, FCG2, FCGR2A1, IGFR2: Low affinity immunoglobulin gamma Fc region |
0.58 |
Evidence |
|
| PPEF1 |
IPI00024186 |
ITPKA |
ITPKA: Inositol-trisphosphate 3-kinase A |
0.58 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
C6orf21 |
LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G |
0.58 |
Evidence |
|
| SUPT5H |
SUPT5H, SPT5, SPT5H: Transcription elongation factor SPT5 |
C20orf77 |
IPI00009659 |
0.58 |
Evidence |
|
| PTK6 |
PTK6, BRK: Tyrosine-protein kinase 6 |
KHDRBS3 |
KHDRBS3, SALP, SLM2: KH domain-containing, RNA-binding, signal transduction-asso |
0.58 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
ADRA2A |
IPI00031712 |
0.58 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.58 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
ADRA2A |
IPI00031712 |
0.58 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.58 |
Evidence |
|
| PGR |
PGR, NR3C3: Progesterone receptor |
RELB |
RELB: Transcription factor RelB |
0.58 |
Evidence |
|
| CDC23 |
CDC23: Cell division cycle protein 23 homolog |
PGAM1 |
PGAM1, PGAMA, CDABP0006: Phosphoglycerate mutase 1 |
0.58 |
Evidence |
|
| CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
TPR |
TPR: Nucleoprotein TPR |
0.58 |
Evidence |
|
| SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
CHC1 |
RCC1: RCC1-I (Fragment) |
0.58 |
Evidence |
|
| CHAF1B |
CHAF1B, CAF1A, CAF1P60, MPHOSPH7, MPP7: Chromatin assembly factor 1 subunit B |
TPR |
TPR: Nucleoprotein TPR |
0.58 |
Evidence |
|
| RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
TFIP11 |
TFIP11, HSPC006: Tuftelin-interacting protein 11 |
0.58 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
0.58 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
0.58 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
PTPN11 |
IPI00298347 |
0.58 |
Evidence |
|
| RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
MAP2K1 |
MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 |
0.58 |
Evidence |
|
| DNAJA1 |
DNAJA1, DNAJ2, HDJ2, HSJ2, HSPF4: DnaJ homolog subfamily A member 1 |
NOC2L |
NOC2L: Nucleolar complex protein 2 homolog |
0.58 |
Evidence |
|
| PTPN1 |
PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
0.58 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
CUL5 |
CUL5, VACM1: Cullin-5 |
0.58 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
PPP1R8 |
IPI00030383 |
0.58 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
GSK3B |
IPI00216190 |
0.58 |
Evidence |
|
| PRKAR1A |
PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.58 |
Evidence |
|